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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S253persisting at this level (not statistically signiﬁcant) until D56. In contrast,
both surgical procedures reduced weight bearing in the operated limb
until D7 only (DMM> sham), both < mBSA.
There were no differences between ipsi- and contra-lateral DRG gene
expression at any time in sham or saline animals. There was no difference
between ipsi- and contra-lateral expression of TRPV1 or TRPV2 in either
model at any time. Ipsilateral ATF3 expressionwas > contra-lateral in both
DMM (D3) and mBSA (D7). In mBSA only, ipsilateral Tac1 (D14) was <, and
Mor1 (D3 &7) was> contra-lateral. In DMM only, ipsilateral TRPA1 (D3 and
D112) and TRPV4 (D112) was > contra-lateral, and ipsilateral CGRP in
DMM was > sham (D3 & D7).
Conclusions: More synovitis and SCB vascular invasion in the post-
inﬂammatory arthropathy (mBSA) was reﬂected in greater change in limb
loading, supporting a link between particular tissue pathologies and pain.
However, changes in DRG expression of speciﬁc pain-related neuropep-
tides (CGRP, TRPV4, TRPA1) were only present in DMM. Interestingly,
despite similar long-term progressive joint destruction, pain outcomes
resolved in both models. Taken together our ﬁndings suggest there may be
temporal and model-related differences in the type of pain, and its
mechanisms. Using appropriate animal models will be critical to under-
standing what regulates OA pain and for developing improved analgesic
therapies.499
ENDOTHELIN AND BRADYKININ ANTAGONISM IMPROVES NOCICEPTIVE
TOLERANCE AND PROTECTS CARILAGE JOINT DEGARDATION IN
OSTEOARTHRITIS
F. Moldovan, G.N. Kaufman, C. Zaouter, P. Sirois. Montreal Univ., Montreal,
QC, Canada
Purpose: Pain is the primary complaint of patients with Osteoarthritis
(OA). Endothelin-1, a vasocontrictor peptide, inﬂuences cartilage
metabolism mainly via endothelin receptor type A (ETA). Along with the
inﬂammatory nonapeptide vasodilator bradykinin (BK), which acts via
bradykinin receptor B1 (BKB1) in chronic inﬂammatory conditions,
these vasoactive factors potentiate joint pain and inﬂammation. Here
we describe a preclinical study of the efﬁcacy of treatment of surgically
induced osteoarthritis with ETA and/or BKB1 speciﬁc peptide
antagonists
Methods: Osteoarthritis was surgically induced in rats by transection of
the right anterior cruciate ligament. Animals were subsequently treated
with weekly intra-articular injections of speciﬁc peptide antagonists of
ETA and/or BKB1 (BQ 123 and R 954) . Hind limb nociception was
measured by static weight bearing biweekly for two months post-opera-
tively. Post-mortem, right knee joints were analyzed radiologically by X-
ray and magnetic resonance, and histologically by the OARSI histopa-
thology assessment system.
Results: Single and dual local ETA and/or BKB1 antagonist treatment
diminished overall limb pain, and accelerated post-operative recovery
after disease induction. Repeated measures analysis of variance of the
static weight bearing data, followed by Tukey post-hoc hypothesis tests,
demonstrated that treatment with R-954, or both BQ-123 and R-954,
signiﬁcantly ameliorated nociceptive tolerance in ACLT animals over the
study period, as compared to saline-treated positive controls (0:0001
P0:0002 Treatments also protected joint radiomorphology and histo-
morphology. We found that single and dual ETA/BKB1 antagonist treat-
ments decreased radiological disease indices, in terms of osteophyte
formation, cartilage thinning, and subchondral bone remodelling, with
dual antagonism being most protective. As well, cartilage T2, increased in
ACLT animals, was decreased by antagonist treatment, which indicates
a cartilage-preserving effect.
Conclusions: Using a rat surgically inducedmodel of OA, we demonstrated
that local treatment with specifc peptide antagonists of ETA and/or BKB1
may slow or stabilize the development of radiomorphological and histo-
morphological changes occurring in OA pathogenesis. Furthermore, we
showed that antagonist treatment accelerated recovery of, and improved
longitudinally, nociceptive tolerance in ACLT animals. Taken together, our
results indicate that blocking ETA and BKB1 improves OA prognostic
indices, which implies that defective signalling might play a role in chronicOA pain. Our results also raise the possibility of targeted receptor antag-
onism as a relevant therapeutic option.
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SPECIFIC KNEE PAIN PATTERNS ON THE KNEE PAIN MAP ARE
ASSOCIATED WITH DIFFERENT LEVELS OF FUNCTIONAL
PERFORMANCE - DATA FROM THE OAI
I.B. James 1, Z. Wang 1, M.J. Hannon 1, C.K. Kwoh 1,2. 1Univ. of Pittsburgh Sch.
of Med., Pittsburgh, PA, USA; 2VA Pittsburgh Hlth.care System, Pittsburgh, PA,
USA
Purpose: Knee osteoarthritis (OA) is the most common cause of knee pain
(KP). While KP is the most cited complaint among older adults visiting
primary care ofﬁces, the etiology of such pain is poorly understood. The
purpose of this study was to examine the relationship between speciﬁc KP
patterns and objective measures of functional performance.
Methods: We conducted a cross-sectional analysis of data from the 24-
month follow up visit (OAI data release 2.1) for 4796 participants in the
Osteoarthritis Initiative (OAI), a multicenter population-based cohort
study designed to identify biomarkers of knee OA development and/or
progression. The Knee Pain Map, an interviewer administered assessment
of speciﬁc KP patterns, was used to identify local, regional, or global KP
patterns vs. no KP. Functional performance was assessed based on times
to complete a 20 meter walk, a 400 meter walk, and 5 repeated chair
stands. Peak isometric quadriceps strength and hamstring strength were
also assessed. Data analysis was conducted using quintiles of perfor-
mance as explanatory variables in multivariate multinomial logistic
regression models controlled for age, gender, race, BMI, depression, hand
OA, history (Hx) of knee injury, Hx of knee surgery, family Hx of knee
replacement, hip OA and Charlson Comorbidity score. Participants who
did not complete the test were placed in the 5th (worst) quintile. Analysis
was performed on a per-person basis for participants who reported
experiencing KP in either knee on the day of their clinic visit or those
who reported KP the past 30 days vs. no KP on the day of their clinic visit
or no KP in either knee in the past 30 days, respectively. In individuals
with bilateral KP, the knee with the most expansive pain pattern (i.e.
global over regional and regional over local pain) was used as the index
knee.
Results: Of the 3262 participants analyzed, on the day of the visit 2085
(63.9%) reported no pain in either knee, 493 (15.1%) reported local pain in
their index knee, 383 (11.7%) reported regional pain in their index knee,
and 301 (9.2%) reported global pain in their index knee. After controlling
for covariates in multivariate analysis, using separate models for each
performance measure, the worst quintiles of 20 meter walk time, 400
meter walk time, repeated chair stand time, and isometric quadriceps
strength showed signiﬁcantly higher rates (vs. the best quintile) of local-
ized KP vs. no KP (p¼0.009, p¼0.019, p<0.001, p<0.001, respectively);
regional KP vs. no KP (p¼0.001, p¼0.004, p<0.001, p<0.001), global KP vs.
no KP (p<0.001, p<0.001, p<0.001, p<0.001); and global KP vs. localized
KP (p¼0.004, p¼0.004, p<0.001, p¼0.015). Global KP vs. regional KP was
only signiﬁcant for the worst quintile of 400 meter walk time and quad-
riceps strength (p¼0.030, p¼0.007). Interestingly, hamstring strength was
signiﬁcant only for the worst quintile and only for regional KP vs. no KP
and regional KP vs. local KP comparisons (p¼0.001, p¼0.028). In a separate
multivariate analysis using all performance variables in one model and
controlling for covariates (see Table 1), the worst quintiles of chair stand
time and isometric quadriceps strength were signiﬁcantly different from
the best quintile for local KP vs. no KP (p¼0.002, p<0.001) and global KP vs.
no KP (p<0.001, p<0.001). For regional KP vs. no KP and global KP vs. local
KP comparisons, only chair stand time was signiﬁcant in the worst quintile
of performance (p<0.001, p¼0.001). An analysis with KP patterns more
broadly deﬁned as KP occurring within the past 30 days yielded similar
results.
Conclusions: The data suggest that speciﬁc KP patterns are associated
with different levels and types of functional disability. Performance on all
tests except hamstring strength varied among the different KP patterns,
and the strongest associations were seen with chair stand time and
quadriceps strength. In general, the worst quintiles of performance
were most strongly associated with global KP, followed by regional KP, and
local KP.
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THE PREVALENCE AND ROLE OF THE CENTRAL PAIN PHENOTYPE IN
PATIENTS UNDERGOING KNEE OR HIP ARTHROPLASTY
K. Phillips, D.A. Williams, A.L. Hassett, M. Morris, A. Urquhart, B.
Hallstrom, D.J. Clauw, C.M. Brummett. Univ. of Michigan, Ann Arbor, MI, USA
Purpose: Joint pain symptoms do not correlate with radiographic struc-
tural damage in osteoarthritis, and the centralization of pain (neurobio-
logical alterations in pain processing like those observed in ﬁbromyalgia)
may play a role in some patients. Approximately 30% of total knee
arthroplasty (TKA) patients and 10% of total hip arthroplasty (THA)
patients have unsatisfactory outcomes following surgery due to subop-
timal pain relief. It is possible that a co-morbid pain sensitivity phenotype
in patients scheduled for THA or TKA could help predict patients likely to
have unsatisfactory outcomes. Thus, a composite index evaluating
augmented central pain processing may be useful as part of an initial
assessment.
Methods: The Analgesic Outcome Study (AOS) is an NIH-funded prospec-
tive, longitudinal, cohort study of chronic post-surgical pain, including
patients undergoing total hip and knee arthroplasty. During the preoper-
ative period, patients completed validated self-report questionnaires,
including the Brief Pain Inventory, the PainDETECT, and the Hospital
Anxiety and Depression Scale. Painful body areas were identiﬁed using the
Michigan Body Map and were combined with the Symptom Severity scale
to create a continuous composite index score for centrally mediated pain
(i.e., ACR survey criteria for ﬁbromyalgia). Descriptive statistics and corre-
lational analyses examined the potential presence and role of centrally
mediated pain in this cohort. Recruitment is ongoing with an enrollment
goal of 2000 lower extremity total joint arthroplasty patients.
Results: To date, 323 lower extremity joint arthroplasty patients have been
evaluated preoperatively. Patient scores on a composite index for centrally
mediated pain were normally distributed, with 8% of patients likely
meeting the ACR survey criteria for ﬁbromyalgia (scores > 13). The
composite index score for centrally mediated pain was directly correlated
with baseline pain intensity, neuropathic pain complaints, anxiety, and
depression and was inversely correlated with positive affect (Table 1).
Differences were noted between hip and knee patients.











PainDETECT 0.368** 0.525** 0.367*
Anxiety 0.303** 0.333* 0.263*
Depression 0.424** 0.453** 0.385**
Positive affect -0.393* -0.495** -0.415**
Spearman's rho correlation, *p < 0.05, **p < 0.0001Conclusions: Prior to surgery, a higher composite index score of cen-
trally mediated pain complaints and symptoms was correlated with self-
report of higher pain, more neuropathic pain descriptors, higher nega-
tive affect, and lower positive affect. Psychological comorbidities and
pain in other locations have previously been associated with failed
outcome from knee arthroplasty. The results of this initial evaluation
suggest that preoperative measures of centrally mediated pain pro-
cessing may allow for subgrouping of TKA and THA patients. Further
studies are needed to assess the utility of measures of central pain
sensitivity in predicting outcome.
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PAIN MANAGEMENT: OBSERVATION AND SIDE EFFECTS
C. Taieb, Sr.. PFSA, Boulogne Billancourt, France
Purpose: Pain treatment is a real challenge for Public Health and
a requirement for the quality and evolution of a health system. It
responds primarily to a humanist and ethical objective, intrinsic to the
dignity of the humankind. The physical pain and moral suffering expe-
rienced during all ages of life make those already weakened by the
disease even more vulnerable. Treatment compliance is essential to the
efﬁcacy of the treatment offered. Side effects or undesirable effects may
be caused by non compliance when they appear in the ﬁrst 24 or 48 hours
after treatment. The objectyive is to describe the side effects perceived
during the ﬁrst 48 hours and spontaneously cited by the subjects treated
with an analgesic.
Methods: Prospective, longitudinal, multicenter observational study,
conducted in France using data collected by the general practitioners who
agreed to participate.
Results: Patients were treated either with a paracetamol-codeine combi-
nation (n¼ 742) or with a paracetamol-tramadol combination (n ¼107).
Nausea / vomiting, dizziness, drowsiness and constipationwere the 4most
commonly cited side effects. In the ﬁrst group, prevalence after 24h was
9.56%, 2.96%, 4.44% and 1.08% respectively, versus 13.89%, 7.41%, 2.78% and
2.78% in the second group. On the 2nd day, prevalence in the ﬁrst group
was 3.9%, 2.01%, 3.4% and 2.8% respectively, versus 11.1%, 3.7%, 1.85% and
2.78% in the second group. Prevalence of at least one side effect perceived
during the 7 days of treatment was 29.74% in the ﬁrst group versus 40.74%
in the second treatment group.
Conclusions: A study published in 2005 (Patients and chronic pain -
Exercermagazine Jan 2005 - Le Goaziou et call) indicated 37% constipation,
24% nausea and vomiting and 22.4% dizziness for a group of patients
undergoing treatment. It appeared that the patients treated with one of
the two drug combinations had fewer complaints of the same side effects.
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BASELINE PRESSURE-PAIN TOLERANCE THRESHOLD PREDICTS THE
CLINICAL OUTCOME OF A WEIGHT LOSS INTERVENTION IN OBESE
KNEE OA PATIENTS: A PROSPECTIVE COHORT STUDY
T.S. Jørgensen 1,2, M. Henriksen 1, R. Christensen 1,3, T. Graven-Nielsen 2, H.
Bliddal 1, A. Jespersen 1. 1 Parker Inst., Copenhagen, Denmark; 2Ctr. for
Sensory-Motor Interaction (SMI), Dept. of Hlth.Sci. and Technology, Aalborg
Univ., Aalborg, Denmark; 3 Inst. of Sports Sci. and Clinical Biomechanics,
Faculty of Hlth.Sci., Univ. of Southern Denmark, Odense, Denmark
Purpose: Knee osteoarthritis (OA) is a chronic pain condition, often
associated with peripheral and central sensitization of the nociceptive
system. Obesity is strongly linked with knee OA and weight-loss inter-
ventions are generally effective in relief of knee OA symptoms. However, it
is unknown if sensitization may restrain improvement in pain. The aim of
the study was to investigate whether baseline pressure-pain sensitivity of
the lower leg can predict the clinical outcome of a dietary intervention in
obese knee OA patients, which could support clinical decision on how to
deliver dietetic support in terms of prioritizing efforts.
Methods: Participants of this prediction study (the CAROT study) included
168 obese (88% of the CAROT cohort) patients with symptomatic knee OA
according to the ACR criteria. The patients completed a dietary interven-
tion, and had a computerized tourniquet cuff pressure algometer
